Literature DB >> 6897404

Identification and DNA sequence of a human apolipoprotein E cDNA clone.

J L Breslow, J McPherson, A L Nussbaum, H W Williams, F Lofquist-Kahl, S K Karathanasis, V I Zannis.   

Abstract

cDNA clones encoding human apolipoprotein E were identified by screening an adult human liver cDNA library with an oligonucleotide probe. The probe was a mixture of synthetic 14-base long DNA oligomers constructed to correspond to all possible codons for apo-E amino acids 218-222. Plasmids from four of the 20 clones selected by this screening procedure were digested with PstI and all had five internal PstI sites with a total length of the cDNA insert of approximately 900 base pairs. DNA sequence analysis of one of these clones, designated pE-301, revealed that it corresponded to apo-E amino acids 81-299, and contained a standard termination codon, polyadenylation signal, and poly A tail. The DNA sequence examined included the known apo-E polymorphic sites at amino acids 112, 145, and 158, and the mutant apo-E phenotypes can all be explained on the basis of a single base substitution in the first position of each of these codons. This work supports the hypothesis that the apo-E polymorphism is due to mutations in the region of DNA coding for the apo-E structural gene.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897404

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13.

Authors:  Ralph Burkhardt; Eimear E Kenny; Jennifer K Lowe; Andrew Birkeland; Rebecca Josowitz; Martha Noel; Jacqueline Salit; Julian B Maller; Itsik Pe'er; Mark J Daly; David Altshuler; Markus Stoffel; Jeffrey M Friedman; Jan L Breslow
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-18       Impact factor: 8.311

2.  Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.

Authors:  E Boerwinkle; G Utermann
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

3.  Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: mechanism of antagonism by testosterone.

Authors:  S P Tam; T K Archer; R G Deeley
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 4.  Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk.

Authors:  G Thompson
Journal:  Br Heart J       Date:  1984-06

5.  Effect of 25-hydroxycholesterol and bile acids on the regulation of cholesterol metabolism in Hep G2 cells.

Authors:  T L Carlson; B A Kottke
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

6.  Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.

Authors:  K Brand; N Mackman; L K Curtiss
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  Characterisation of mRNAs encoding the precursor for human apolipoprotein CI.

Authors:  T J Knott; M E Robertson; L M Priestley; M Urdea; S Wallis; J Scott
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

8.  LNA-enhanced detection of single nucleotide polymorphisms in the apolipoprotein E.

Authors:  Nana Jacobsen; Joan Bentzen; Michael Meldgaard; Mogens Havsteen Jakobsen; Mogens Fenger; Sakari Kauppinen; Jan Skouv
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

9.  Evolution of apolipoprotein E: mouse sequence and evidence for an 11-nucleotide ancestral unit.

Authors:  T B Rajavashisth; J S Kaptein; K L Reue; A J Lusis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  Tight linkage between myotonic dystrophy and apolipoprotein E genes revealed with allele-specific oligonucleotides.

Authors:  B Smeets; J Poddighe; H Brunner; H H Ropers; B Wieringa
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.